<author><surname>Rockstroh</surname> <given-names>JK</given-names> </author><author><surname>Mocroft</surname> <given-names>A</given-names> </author><author><surname>Soriano</surname> <given-names>V</given-names> </author><author><surname>Tural</surname> <given-names>C</given-names> </author><author><surname>Losso</surname> <given-names>MH</given-names> </author><author><surname>Horban</surname> <given-names>A</given-names> </author><author><surname>Kirk</surname> <given-names>O</given-names> </author><author><surname>Phillips</surname> <given-names>A</given-names> </author><author><surname>Ledergerber</surname> <given-names>B</given-names> </author><author><surname>Lundgren</surname> <given-names>J</given-names> </author><title>Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy</title><source>J Infect Dis</source><year>2005</year><volume>192</volume><fpage>992</fpage><lpage>1002</lpage>
<author><surname>Abdala</surname> <given-names>N</given-names> </author><author><surname>Carney</surname> <given-names>JM</given-names> </author><author><surname>Durante</surname> <given-names>AJ</given-names> </author><author><surname>Klimov</surname> <given-names>N</given-names> </author><author><surname>Ostrovski</surname> <given-names>D</given-names> </author><author><surname>Somlai</surname> <given-names>AM</given-names> </author><author><surname>Kozlov</surname> <given-names>A</given-names> </author><author><surname>Heimer</surname> <given-names>R</given-names> </author><title>Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia</title><source>Int J STD AIDS</source><year>2003</year><volume>14</volume><fpage>697</fpage><lpage>703</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names> </author><author><surname>Vlahov</surname> <given-names>D</given-names> </author><author><surname>Solomon</surname> <given-names>L</given-names> </author><author><surname>Cohn</surname> <given-names>S</given-names> </author><author><surname>Taylor</surname> <given-names>E</given-names> </author><author><surname>Garfein</surname> <given-names>R</given-names> </author><author><surname>Nelson</surname> <given-names>KE</given-names> </author><title>Correlates of hepatitis C virus infections among injection drug users in Baltimore</title><source>Medicine</source><year>1995</year><volume>74</volume><fpage>212</fpage><lpage>220</lpage>
<author><surname>Lincoln</surname> <given-names>D</given-names> </author><author><surname>Petoumenos</surname> <given-names>K</given-names> </author><author><surname>Dore</surname> <given-names>GJ</given-names> </author><title>HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy</title><source>HIV Med</source><year>2003</year><volume>4</volume><fpage>241</fpage><lpage>249</lpage>
<author><surname>Solomon</surname> <given-names>SS</given-names> </author><author><surname>SriKrishnan</surname> <given-names>AK</given-names> </author><author><surname>Mehta</surname> <given-names>SH</given-names> </author><author><surname>Vasudevan</surname> <given-names>CK</given-names> </author><author><surname>Murugavel</surname> <given-names>KG</given-names> </author><author><surname>Thamburaj</surname> <given-names>E</given-names> </author><author><surname>Anand</surname> <given-names>S</given-names> </author><author><surname>Kumar</surname> <given-names>MS</given-names> </author><author><surname>Latkin</surname> <given-names>C</given-names> </author><author><surname>Solomon</surname> <given-names>S</given-names> </author><author><surname>Celentano</surname> <given-names>DD</given-names> </author><title>High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern</title><source>J Acquir Immune Defic Syndr</source><year>2008</year><volume>49</volume><fpage>327</fpage><lpage>332</lpage>
<author><surname>Quan</surname> <given-names>VM</given-names> </author><author><surname>Go</surname> <given-names>VF</given-names> </author><author><surname>Nam</surname> <given-names>LV</given-names> </author><author><surname>Bergenstrom</surname> <given-names>A</given-names> </author><author><surname>Thuoc</surname> <given-names>NP</given-names> </author><author><surname>Zenilman</surname> <given-names>J</given-names> </author><author><surname>Latkin</surname> <given-names>C</given-names> </author><author><surname>Celentano</surname> <given-names>DD</given-names> </author><title>Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study</title><source>AIDS Care</source><year>2009</year><volume>21</volume><fpage>7</fpage><lpage>16</lpage>
<author><surname>Tan</surname> <given-names>Y</given-names> </author><author><surname>Wei</surname> <given-names>QH</given-names> </author><author><surname>Chen</surname> <given-names>LJ</given-names> </author><author><surname>Chan</surname> <given-names>PC</given-names> </author><author><surname>Lai</surname> <given-names>WS</given-names> </author><author><surname>He</surname> <given-names>ML</given-names> </author><author><surname>Kung</surname> <given-names>HF</given-names> </author><author><surname>Lee</surname> <given-names>SS</given-names> </author><title>Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China</title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e3608</fpage>
<author><surname>Garten</surname> <given-names>RJ</given-names> </author><author><surname>Lai</surname> <given-names>S</given-names> </author><author><surname>Zhang</surname> <given-names>J</given-names> </author><author><surname>Liu</surname> <given-names>W</given-names> </author><author><surname>Chen</surname> <given-names>J</given-names> </author><author><surname>Vlahov</surname> <given-names>D</given-names> </author><author><surname>Yu</surname> <given-names>XF</given-names> </author><title>Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China</title><source>Int J Epidemiol</source><year>2004</year><volume>33</volume><fpage>182</fpage><lpage>188</lpage>
<author><surname>McGovern</surname> <given-names>BH</given-names> </author><author><surname>Wurcel</surname> <given-names>A</given-names> </author><author><surname>Kim</surname> <given-names>AY</given-names> </author><author><surname>Schulze zur</surname> <given-names>WJ</given-names> </author><author><surname>Bica</surname> <given-names>I</given-names> </author><author><surname>Zaman</surname> <given-names>MT</given-names> </author><author><surname>Timm</surname> <given-names>J</given-names> </author><author><surname>Walker</surname> <given-names>BD</given-names> </author><author><surname>Lauer</surname> <given-names>GM</given-names> </author><title>Acute hepatitis C virus infection in incarcerated injection drug users</title><source>Clin Infect Dis</source><year>2006</year><volume>42</volume><fpage>1663</fpage><lpage>1670</lpage>
<author><surname>Holsen</surname> <given-names>DS</given-names> </author><author><surname>Harthug</surname> <given-names>S</given-names> </author><author><surname>Myrmel</surname> <given-names>H</given-names> </author><title>Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway</title><source>Eur J Clin Microbiol Infect Dis</source><year>1993</year><volume>12</volume><fpage>673</fpage><lpage>676</lpage>
<author><surname>Sulkowski</surname> <given-names>MS</given-names> </author><author><surname>Thomas</surname> <given-names>DL</given-names> </author><title>Hepatitis C in the HIV-infected patient</title><source>Clin Liver Dis</source><year>2003</year><volume>7</volume><fpage>179</fpage><lpage>194</lpage>
<author><surname>Danta</surname> <given-names>M</given-names> </author><author><surname>Brown</surname> <given-names>D</given-names> </author><author><surname>Bhagani</surname> <given-names>S</given-names> </author><author><surname>Pybus</surname> <given-names>OG</given-names> </author><author><surname>Sabin</surname> <given-names>CA</given-names> </author><author><surname>Nelson</surname> <given-names>M</given-names> </author><author><surname>Fisher</surname> <given-names>M</given-names> </author><author><surname>Johnson</surname> <given-names>AM</given-names> </author><author><surname>Dusheiko</surname> <given-names>GM</given-names> </author><title>Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours</title><source>AIDS</source><year>2007</year><volume>21</volume><fpage>983</fpage><lpage>991</lpage>
<author><surname>Fierer</surname> <given-names>DS</given-names> </author><author><surname>Uriel</surname> <given-names>AJ</given-names> </author><author><surname>Carriero</surname> <given-names>DC</given-names> </author><author><surname>Klepper</surname> <given-names>A</given-names> </author><author><surname>Dieterich</surname> <given-names>DT</given-names> </author><author><surname>Mullen</surname> <given-names>MP</given-names> </author><author><surname>Thung</surname> <given-names>SN</given-names> </author><author><surname>Fiel</surname> <given-names>MI</given-names> </author><author><surname>Branch</surname> <given-names>AD</given-names> </author><title>Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study</title><source>J Infect Dis</source><year>2008</year><volume>198</volume><fpage>683</fpage><lpage>686</lpage>
<author><surname>van de Laar</surname> <given-names>T</given-names> </author><author><surname>Pybus</surname> <given-names>O</given-names> </author><author><surname>Bruisten</surname> <given-names>S</given-names> </author><author><surname>Brown</surname> <given-names>D</given-names> </author><author><surname>Nelson</surname> <given-names>M</given-names> </author><author><surname>Bhagani</surname> <given-names>S</given-names> </author><author><surname>Vogel</surname> <given-names>M</given-names> </author><author><surname>Baumgarten</surname> <given-names>A</given-names> </author><author><surname>Chaix</surname> <given-names>ML</given-names> </author><author><surname>Fisher</surname> <given-names>M</given-names> </author><author><surname>Gotz</surname> <given-names>H</given-names> </author><author><surname>Matthews</surname> <given-names>GV</given-names> </author><author><surname>Neifer</surname> <given-names>S</given-names> </author><author><surname>White</surname> <given-names>P</given-names> </author><author><surname>Rawlinson</surname> <given-names>W</given-names> </author><author><surname>Pol</surname> <given-names>S</given-names> </author><author><surname>Rockstroh</surname> <given-names>J</given-names> </author><author><surname>Coutinho</surname> <given-names>R</given-names> </author><author><surname>Dore</surname> <given-names>GJ</given-names> </author><author><surname>Dusheiko</surname> <given-names>GM</given-names> </author><author><surname>Danta</surname> <given-names>M</given-names> </author><title>Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men</title><source>Gastroenterology</source><year>2009</year><volume>136</volume><fpage>1609</fpage><lpage>1617</lpage>
<author><surname>Gerberding</surname> <given-names>JL</given-names> </author><title>Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study</title><source>J Infect Dis</source><year>1994</year><volume>170</volume><fpage>1410</fpage><lpage>1417</lpage>
<author><surname>Goedert</surname> <given-names>JJ</given-names> </author><author><surname>Chen</surname> <given-names>BE</given-names> </author><author><surname>Preiss</surname> <given-names>L</given-names> </author><author><surname>Aledort</surname> <given-names>LM</given-names> </author><author><surname>Rosenberg</surname> <given-names>PS</given-names> </author><title>Reconstruction of the Hepatitis C Virus Epidemic in the US Hemophilia Population, 1940-1990</title><source>Am J Epidemiol</source><year>2007</year>
<author><surname>Ticehurst</surname> <given-names>JR</given-names> </author><author><surname>Hamzeh</surname> <given-names>FM</given-names> </author><author><surname>Thomas</surname> <given-names>DL</given-names> </author><title>Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis</title><source>J Clin Microbiol</source><year>2007</year><volume>45</volume><fpage>2426</fpage><lpage>2433</lpage>
<author><surname>Mellors</surname> <given-names>JW</given-names> </author><author><surname>Rinaldo</surname> <given-names>CRJ</given-names> </author><author><surname>Gupta</surname> <given-names>P</given-names> </author><author><surname>White</surname> <given-names>RM</given-names> </author><author><surname>Todd</surname> <given-names>JA</given-names> </author><author><surname>Kingsley</surname> <given-names>LA</given-names> </author><title>Prognosis in HIV-1 infection predicted by the quantity of virus in plasma</title><source>Science</source><year>1996</year><volume>272</volume><fpage>1167</fpage><lpage>1170</lpage>
<author><surname>Drucker</surname> <given-names>E</given-names> </author><author><surname>Alcabes</surname> <given-names>PG</given-names> </author><author><surname>Marx</surname> <given-names>PA</given-names> </author><title>The injection century: massive unsterile injections and the emergence of human pathogens</title><source>Lancet</source><year>2001</year><volume>358</volume><fpage>1989</fpage><lpage>1992</lpage>
<author><surname>Magiorkinis</surname> <given-names>G</given-names> </author><author><surname>Magiorkinis</surname> <given-names>E</given-names> </author><author><surname>Paraskevis</surname> <given-names>D</given-names> </author><author><surname>Ho</surname> <given-names>SY</given-names> </author><author><surname>Shapiro</surname> <given-names>B</given-names> </author><author><surname>Pybus</surname> <given-names>OG</given-names> </author><author><surname>Allain</surname> <given-names>JP</given-names> </author><author><surname>Hatzakis</surname> <given-names>A</given-names> </author><title>The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis</title><source>PLoS Med</source><year>2009</year><volume>6</volume><fpage>e1000198</fpage>
<author><surname>Frank</surname> <given-names>C</given-names> </author><author><surname>Mohamed</surname> <given-names>MK</given-names> </author><author><surname>Strickland</surname> <given-names>GT</given-names> </author><author><surname>Lavanchy</surname> <given-names>D</given-names> </author><author><surname>Arthur</surname> <given-names>RR</given-names> </author><author><surname>Magder</surname> <given-names>LS</given-names> </author><author><surname>El Khoby</surname> <given-names>T</given-names> </author><author><surname>Abdel-Wahab</surname> <given-names>Y</given-names> </author><author><surname>Aly Ohn</surname> <given-names>ES</given-names> </author><author><surname>Anwar</surname> <given-names>W</given-names> </author><author><surname>Sallam</surname> <given-names>I</given-names> </author><title>The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt</title><source>Lancet</source><year>2000</year><volume>355</volume><fpage>887</fpage><lpage>891</lpage>
<author><surname>Garfein</surname> <given-names>RS</given-names> </author><author><surname>Doherty</surname> <given-names>MC</given-names> </author><author><surname>Monterroso</surname> <given-names>ER</given-names> </author><author><surname>Thomas</surname> <given-names>DL</given-names> </author><author><surname>Nelson</surname> <given-names>KE</given-names> </author><author><surname>Vlahov</surname> <given-names>D</given-names> </author><title>Prevalence and incidence of hepatitis C virus infection among young adult injection drug users</title><source>J Acquir Immune Defic Syndr Hum Retrovirol</source><year>1998</year><volume>18</volume><issue>Suppl 1</issue><fpage>S11</fpage><lpage>S19</lpage>
<author><surname>Quinn</surname> <given-names>TC</given-names> </author><author><surname>Groseclose</surname> <given-names>SL</given-names> </author><author><surname>Spence</surname> <given-names>M</given-names> </author><author><surname>Provost</surname> <given-names>V</given-names> </author><author><surname>Hook</surname> <given-names>EW</given-names> <suffix>III</suffix> </author><title>Evolution of the human immunodeficiency virus epidemic among patients attending sexually transmitted disease clinics: a decade of experience</title><source>J Infect Dis</source><year>1992</year><volume>165</volume><fpage>541</fpage><lpage>544</lpage>
<author><surname>Kelen</surname> <given-names>GD</given-names> </author><author><surname>Green</surname> <given-names>GB</given-names> </author><author><surname>Purcell</surname> <given-names>RH</given-names> </author><author><surname>Chan</surname> <given-names>DW</given-names> </author><author><surname>Qaqish</surname> <given-names>BF</given-names> </author><author><surname>Sivertson</surname> <given-names>KT</given-names> </author><author><surname>Quinn</surname> <given-names>TC</given-names> </author><title>Hepatitis B and hepatitis C in emergency department patients</title><source>N Engl J Med</source><year>1992</year><volume>326</volume><fpage>1399</fpage><lpage>1404</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names> </author><author><surname>Astemborski</surname> <given-names>J</given-names> </author><author><surname>Rai</surname> <given-names>RM</given-names> </author><author><surname>Anania</surname> <given-names>FA</given-names> </author><author><surname>Schaeffer</surname> <given-names>M</given-names> </author><author><surname>Galai</surname> <given-names>N</given-names> </author><author><surname>Nolt</surname> <given-names>K</given-names> </author><author><surname>Nelson</surname> <given-names>KE</given-names> </author><author><surname>Strathdee</surname> <given-names>SA</given-names> </author><author><surname>Johnson</surname> <given-names>L</given-names> </author><author><surname>Laeyendecker</surname> <given-names>O</given-names> </author><author><surname>Boitnott</surname> <given-names>J</given-names> </author><author><surname>Wilson</surname> <given-names>LE</given-names> </author><author><surname>Vlahov</surname> <given-names>D</given-names> </author><title>The natural history of hepatitis C virus infection: host, viral, and environmental factors</title><source>JAMA</source><year>2000</year><volume>284</volume><fpage>450</fpage><lpage>456</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names> </author><author><surname>Astemborski</surname> <given-names>J</given-names> </author><author><surname>Vlahov</surname> <given-names>D</given-names> </author><author><surname>Strathdee</surname> <given-names>SA</given-names> </author><author><surname>Ray</surname> <given-names>SC</given-names> </author><author><surname>Nelson</surname> <given-names>KE</given-names> </author><author><surname>Galai</surname> <given-names>N</given-names> </author><author><surname>Nolt</surname> <given-names>KR</given-names> </author><author><surname>Laeyendecker</surname> <given-names>O</given-names> </author><author><surname>Todd</surname> <given-names>JA</given-names> </author><title>Determinants of the quantity of hepatitis C virus RNA</title><source>J Infect Dis</source><year>2000</year><volume>181</volume><fpage>844</fpage><lpage>851</lpage>
<author><surname>Torriani</surname> <given-names>FJ</given-names> </author><author><surname>Rodriguez-Torres</surname> <given-names>M</given-names> </author><author><surname>Rockstroh</surname> <given-names>JK</given-names> </author><author><surname>Lissen</surname> <given-names>E</given-names> </author><author><surname>Gonzalez-Garcia</surname> <given-names>J</given-names> </author><author><surname>Lazzarin</surname> <given-names>A</given-names> </author><author><surname>Carosi</surname> <given-names>G</given-names> </author><author><surname>Sasadeusz</surname> <given-names>J</given-names> </author><author><surname>Katlama</surname> <given-names>C</given-names> </author><author><surname>Montaner</surname> <given-names>J</given-names> </author><author><surname>Sette</surname> <given-names>H</given-names> </author><author><surname>Passe</surname> <given-names>S</given-names> </author><author><surname>De Pamphilis</surname> <given-names>J</given-names> </author><author><surname>Duff</surname> <given-names>F</given-names> </author><author><surname>Schrenk</surname> <given-names>UM</given-names> </author><author><surname>Dieterich</surname> <given-names>DT</given-names> </author><title>Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients</title><source>N Engl J Med</source><year>2004</year><volume>351</volume><fpage>438</fpage><lpage>450</lpage>
<author><surname>Hadziyannis</surname> <given-names>SJ</given-names> </author><author><surname>Sette</surname> <given-names>H</given-names> </author><author><surname>Morgan</surname> <given-names>TR</given-names> </author><author><surname>Balan</surname> <given-names>V</given-names> </author><author><surname>Diago</surname> <given-names>M</given-names> </author><author><surname>Marcellin</surname> <given-names>P</given-names> </author><author><surname>Ramadori</surname> <given-names>G</given-names> </author><author><surname>Bodenheimer</surname> <given-names>H</given-names> </author><author><surname>Bernstein</surname> <given-names>D</given-names> </author><author><surname>Rizzetto</surname> <given-names>M</given-names> </author><author><surname>Zeuzem</surname> <given-names>S</given-names> </author><author><surname>Pockros</surname> <given-names>PJ</given-names> </author><author><surname>Lin</surname> <given-names>A</given-names> </author><author><surname>Ackrill</surname> <given-names>AM</given-names> </author><title>Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose</title><source>Ann Intern Med</source><year>2004</year><volume>140</volume><fpage>346</fpage><lpage>355</lpage>
<author><surname>Graham</surname> <given-names>CS</given-names> </author><author><surname>Baden</surname> <given-names>LR</given-names> </author><author><surname>Yu</surname> <given-names>E</given-names> </author><author><surname>Mrus</surname> <given-names>JM</given-names> </author><author><surname>Carnie</surname> <given-names>J</given-names> </author><author><surname>Heeren</surname> <given-names>T</given-names> </author><author><surname>Koziel</surname> <given-names>MJ</given-names> </author><title>Influence of human immunodeficiency virus infection on the course of hepatitis c virus infection: a meta-analysis</title><source>Clin Infect Dis</source><year>2001</year><volume>33</volume><fpage>562</fpage><lpage>569</lpage>
<author><surname>Goedert</surname> <given-names>JJ</given-names> </author><author><surname>Eyster</surname> <given-names>ME</given-names> </author><author><surname>Lederman</surname> <given-names>MM</given-names> </author><author><surname>Mandalaki</surname> <given-names>T</given-names> </author><author><surname>De Moerloose</surname> <given-names>P</given-names> </author><author><surname>White</surname> <given-names>GC</given-names> </author><author><surname>Angiolillo</surname> <given-names>AL</given-names> </author><author><surname>Luban</surname> <given-names>NL</given-names> </author><author><surname>Sherman</surname> <given-names>KE</given-names> </author><author><surname>Manco-Johnson</surname> <given-names>M</given-names> </author><author><surname>Preiss</surname> <given-names>L</given-names> </author><author><surname>Leissinger</surname> <given-names>C</given-names> </author><author><surname>Kessler</surname> <given-names>CM</given-names> </author><author><surname>Cohen</surname> <given-names>AR</given-names> </author><author><surname>DiMichele</surname> <given-names>D</given-names> </author><author><surname>Hilgartner</surname> <given-names>MW</given-names> </author><author><surname>Aledort</surname> <given-names>LM</given-names> </author><author><surname>Kroner</surname> <given-names>BL</given-names> </author><author><surname>Rosenberg</surname> <given-names>PS</given-names> </author><author><surname>Hatzakis</surname> <given-names>A</given-names> </author><title>End-stage liver disease in persons with hemophilia and transfusion- associated infections</title><source>Blood</source><year>2002</year><volume>100</volume><fpage>1584</fpage><lpage>1589</lpage>
<author><surname>Chung</surname> <given-names>RT</given-names> </author><author><surname>Evans</surname> <given-names>SR</given-names> </author><author><surname>Yang</surname> <given-names>Y</given-names> </author><author><surname>Theodore</surname> <given-names>D</given-names> </author><author><surname>Valdez</surname> <given-names>H</given-names> </author><author><surname>Clark</surname> <given-names>R</given-names> </author><author><surname>Shikuma</surname> <given-names>C</given-names> </author><author><surname>Nevin</surname> <given-names>T</given-names> </author><author><surname>Sherman</surname> <given-names>KE</given-names> </author>AIDS Clinical Trials Groups 383 Study Team<title>Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects</title><source>AIDS</source><year>2002</year><volume>16</volume><fpage>1915</fpage><lpage>1923</lpage>
<author><surname>Lohse</surname> <given-names>N</given-names> </author><author><surname>Hansen</surname> <given-names>AB</given-names> </author><author><surname>Pedersen</surname> <given-names>G</given-names> </author><author><surname>Kronborg</surname> <given-names>G</given-names> </author><author><surname>Gerstoft</surname> <given-names>J</given-names> </author><author><surname>Sorensen</surname> <given-names>HT</given-names> </author><author><surname>Vaeth</surname> <given-names>M</given-names> </author><author><surname>Obel</surname> <given-names>N</given-names> </author><title>Survival of persons with and without HIV infection in Denmark, 1995-2005</title><source>Ann Intern Med</source><year>2007</year><volume>146</volume><fpage>87</fpage><lpage>95</lpage>
<author><surname>Weber</surname> <given-names>R</given-names> </author><author><surname>Sabin</surname> <given-names>CA</given-names> </author><author><surname>Friis-Moller</surname> <given-names>N</given-names> </author><author><surname>Reiss</surname> <given-names>P</given-names> </author><author><surname>El Sadr</surname> <given-names>WM</given-names> </author><author><surname>Kirk</surname> <given-names>O</given-names> </author><author><surname>Dabis</surname> <given-names>F</given-names> </author><author><surname>Law</surname> <given-names>MG</given-names> </author><author><surname>Pradier</surname> <given-names>C</given-names> </author><author><surname>De Wit</surname> <given-names>S</given-names> </author><author><surname>Akerlund</surname> <given-names>B</given-names> </author><author><surname>Calvo</surname> <given-names>G</given-names> </author><author><surname>Monforte</surname> <given-names>A</given-names> </author><author><surname>Rickenbach</surname> <given-names>M</given-names> </author><author><surname>Ledergerber</surname> <given-names>B</given-names> </author><author><surname>Phillips</surname> <given-names>AN</given-names> </author><author><surname>Lundgren</surname> <given-names>JD</given-names> </author><title>Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study</title><source>Arch Intern Med</source><year>2006</year><volume>166</volume><fpage>1632</fpage><lpage>1641</lpage>
<author><surname>Bica</surname> <given-names>I</given-names> </author><author><surname>McGovern</surname> <given-names>B</given-names> </author><author><surname>Dhar</surname> <given-names>R</given-names> </author><author><surname>Stone</surname> <given-names>D</given-names> </author><author><surname>McGowan</surname> <given-names>K</given-names> </author><author><surname>Scheib</surname> <given-names>R</given-names> </author><author><surname>Snydman</surname> <given-names>DR</given-names> </author><title>Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection</title><source>Clin Infect Dis</source><year>2001</year><volume>32</volume><fpage>492</fpage><lpage>497</lpage>
<author><surname>Janke</surname> <given-names>EA</given-names> </author><author><surname>McGraw</surname> <given-names>S</given-names> </author><author><surname>Garcia-Tsao</surname> <given-names>G</given-names> </author><author><surname>Fraenkel</surname> <given-names>L</given-names> </author><title>Psychosocial issues in hepatitis C: a qualitative analysis</title><source>Psychosomatics</source><year>2008</year><volume>49</volume><fpage>494</fpage><lpage>501</lpage>
<author><surname>Marcellin</surname> <given-names>F</given-names> </author><author><surname>Preau</surname> <given-names>M</given-names> </author><author><surname>Ravaux</surname> <given-names>I</given-names> </author><author><surname>Dellamonica</surname> <given-names>P</given-names> </author><author><surname>Spire</surname> <given-names>B</given-names> </author><author><surname>Carrieri</surname> <given-names>MP</given-names> </author><title>Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research</title><source>HIV Clin Trials</source><year>2007</year><volume>8</volume><fpage>320</fpage><lpage>327</lpage>
<author><surname>Mahoney</surname> <given-names>FJ</given-names> </author><author><surname>Stewart</surname> <given-names>K</given-names> </author><author><surname>Hu</surname> <given-names>HX</given-names> </author><author><surname>Coleman</surname> <given-names>P</given-names> </author><author><surname>Alter</surname> <given-names>MJ</given-names> </author><title>Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States</title><source>Arch Intern Med</source><year>1997</year><volume>157</volume><fpage>2601</fpage><lpage>2605</lpage>
<author><surname>Rockstroh</surname> <given-names>JK</given-names> </author><author><surname>Bhagani</surname> <given-names>S</given-names> </author><author><surname>Benhamou</surname> <given-names>Y</given-names> </author><author><surname>Bruno</surname> <given-names>R</given-names> </author><author><surname>Mauss</surname> <given-names>S</given-names> </author><author><surname>Peters</surname> <given-names>L</given-names> </author><author><surname>Puoti</surname> <given-names>M</given-names> </author><author><surname>Soriano</surname> <given-names>V</given-names> </author><author><surname>Tural</surname> <given-names>C</given-names> </author><title>Europeans AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults</title><source>HIV Med</source><year>2008</year><volume>9</volume><fpage>82</fpage><lpage>88</lpage>
<author><surname>Ghany</surname> <given-names>MG</given-names> </author><author><surname>Strader</surname> <given-names>DB</given-names> </author><author><surname>Thomas</surname> <given-names>DL</given-names> </author><author><surname>Seeff</surname> <given-names>LB</given-names> </author><title>Diagnosis, management, and treatment of hepatitis C: An update</title><source>Hepatology</source><year>2009</year><volume>49</volume><issue>4</issue><fpage>1335</fpage><lpage>1374</lpage>
Centers for Disease Control and Prevention<title>Guidelines for Preventing Opportunistic Infections in HIV-Infected Adults and Adolescents - Recommendations from the CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America</title><source>MMWR</source><year>2009</year><volume>58</volume><fpage>1</fpage><lpage>206</lpage>
<author><surname>Zhou</surname> <given-names>J</given-names> </author><author><surname>Dore</surname> <given-names>GJ</given-names> </author><author><surname>Zhang</surname> <given-names>F</given-names> </author><author><surname>Lim</surname> <given-names>PL</given-names> </author><author><surname>Chen</surname> <given-names>YM</given-names> </author><title>Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database</title><source>J Gastroenterol Hepatol</source><year>2007</year><volume>22</volume><fpage>1510</fpage><lpage>1518</lpage>
<author><surname>Lee</surname> <given-names>SR</given-names> </author><author><surname>Yearwood</surname> <given-names>GD</given-names> </author><author><surname>Guillon</surname> <given-names>GB</given-names> </author><author><surname>Kurtz</surname> <given-names>LA</given-names> </author><author><surname>Fischl</surname> <given-names>M</given-names> </author><author><surname>Friel</surname> <given-names>T</given-names> </author><author><surname>Berne</surname> <given-names>CA</given-names> </author><author><surname>Kardos</surname> <given-names>KW</given-names> </author><title>Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection</title><source>J Clin Virol</source><year>2010</year><volume>48</volume><fpage>15</fpage><lpage>17</lpage>
<author><surname>Soriano</surname> <given-names>V</given-names> </author><author><surname>Maida</surname> <given-names>I</given-names> </author><author><surname>Nunez</surname> <given-names>M</given-names> </author><author><surname>Garcia-Samaniego</surname> <given-names>J</given-names> </author><author><surname>Barreiro</surname> <given-names>P</given-names> </author><author><surname>Martin-Carbonero</surname> <given-names>L</given-names> </author><author><surname>Gonzalez-Lahoz</surname> <given-names>J</given-names> </author><title>Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies</title><source>Antivir Ther</source><year>2004</year><volume>9</volume><fpage>987</fpage><lpage>992</lpage>
<author><surname>Berenguer</surname> <given-names>J</given-names> </author><author><surname>Alvarez-Pellicer</surname> <given-names>J</given-names> </author><author><surname>Martin</surname> <given-names>PM</given-names> </author><author><surname>Lopez-Aldeguer</surname> <given-names>J</given-names> </author><author><surname>Von-Wichmann</surname> <given-names>MA</given-names> </author><author><surname>Quereda</surname> <given-names>C</given-names> </author><author><surname>Mallolas</surname> <given-names>J</given-names> </author><author><surname>Sanz</surname> <given-names>J</given-names> </author><author><surname>Tural</surname> <given-names>C</given-names> </author><author><surname>Bellon</surname> <given-names>JM</given-names> </author><author><surname>Gonzalez-Garcia</surname> <given-names>J</given-names> </author><title>Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus</title><source>Hepatology</source><year>2009</year><volume>50</volume><fpage>407</fpage><lpage>413</lpage>
<author><surname>McHutchison</surname> <given-names>JG</given-names> </author><author><surname>Everson</surname> <given-names>GT</given-names> </author><author><surname>Gordon</surname> <given-names>SC</given-names> </author><author><surname>Jacobson</surname> <given-names>IM</given-names> </author><author><surname>Sulkowski</surname> <given-names>M</given-names> </author><author><surname>Kauffman</surname> <given-names>R</given-names> </author><author><surname>McNair</surname> <given-names>L</given-names> </author><author><surname>Alam</surname> <given-names>J</given-names> </author><author><surname>Muir</surname> <given-names>AJ</given-names> </author><title>Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</title><source>N Engl J Med</source><year>2009</year><volume>360</volume><fpage>1827</fpage><lpage>1838</lpage>
<author><surname>Villano</surname> <given-names>SA</given-names> </author><author><surname>Vlahov</surname> <given-names>D</given-names> </author><author><surname>Nelson</surname> <given-names>KE</given-names> </author><author><surname>Lyles</surname> <given-names>CM</given-names> </author><author><surname>Cohn</surname> <given-names>S</given-names> </author><author><surname>Thomas</surname> <given-names>DL</given-names> </author><title>Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland</title><source>J Clin Microbiol</source><year>1997</year><volume>35</volume><fpage>3274</fpage><lpage>7</lpage>
<author><surname>Thomas</surname> <given-names>DL</given-names> </author><title>Curing hepatitis C with pills: a step toward global control</title><source>Lancet</source><year>2010</year><volume>376</volume><fpage>1441</fpage><lpage>2</lpage>